To evaluate the potential of the PrPc/FOXO3a/KLF5 axis to be prognostic in aggressive colon cancer, we examined a cohort of 46 Grade 3 patients for survival rates based on expression. This evidence concerns the gene KLF5 and colonic neoplasm.